Hofseth BioCare aim to serve the financial market with precise and relevant information about the company to ensure that the share price reflects the underlying values and future prospects. In this section you will find the latest news, presentations, reports and other useful information.
Stock Exchange Notices


    Why Hofseth BioCare?

    • New advanced proprietary process technology
    • Producing premium products
    • Attractive market proposition
    • State of the art production facilities
    • Attractive partner model for further growth
    • Upside potential within pharma segments
    • Management with highly relevant experience


    IR Contact

    Roger Hofseth

    Chief Executive Officer

    Tel +47 951 47 941



    Jon Olav Ødegård

    Chief Financial Officer

    Tel +47 936 32 966